No kekahi symptoms, a me ka hōʻike pehea e hana ventricular tachycardia?

Ua characterizes ventricular tachycardia accelerating naau ana no 100 kui iho oe a. / Min. me ka piko o ka hanana i loko o ka ventricle. I ka 90% o ka hihia ia ia lŘlŘ i loko o kanaka me ke aloha lesions o ka naau pāpana. Loa pinepine, i ka pāpana hana maʻamau me ka coronary artery maʻi hou pili. Aia Ua hoi he tachycardia hiki i myocardial infarction, congenital a me ka rheumatic naʻau maʻi a me nāʻano likeʻole o nā complications ma hope o Inc me ka psychotropic ai 'ole kekahi anesthetics.

symptoms

Ke pahiki o keia maʻi maoli me ka elemakule. Men hooleiiaʻi mawaho aku la ia ia i ka nui loa ma mua o nā wāhine. People kaikaina ma mua o 35 makahiki e ku e ia i ke kāʻei kua o ka myocarditis, hypertrophic cardiomyopathy hiki i hoʻomōhala ventricular tachycardia. Nā symptoms e like penei:

• i ka hoohalike o palpitations, pōniuniu, uunu nui;
• pokole o ka hanu, umauma eha;
• Throbbing i loko o ka'ā'ī;
• ma kekahi hihia o ka ho'āhewa wale 'o ka nawaliwali, a me ka maʻule hou ihola nō.

pathophysiology

Ventricular tachycardia ia lŘlŘ i loko o nā 'ano apau loa: monomorphic a me polymorphic tachycardia. Monomorphic? Ueo ua wehewehe aku ma ke kaʻina o nā lāʻau ikiʻai wale excitation ua mālama ikaika. Ua hana ia na hoike o keia ano o ka tachycardia ia lŘlŘ i loko o kanaka me ka structurally maʻamau naau. Ma kēia hihia, ka lapaʻau prognosis mea IeAUPIIe, IAa IO maikaʻi. Polymorphic ventricular tachycardia distinguishes variability ma ke kaʻina o ka ho'ā hope o na ventricles. Ke kumu o ka maʻi i lilo myocarditis, ischemia a aaiaoe abnormalities i loko o ka 'ole o ka ion kaha.

tachycardia lapaʻau

Lapaʻau o ventricular tachycardia ua paʻa ma ka hana o antiarrhythmic ai ', i kŰlń ao ma luna o ka kāʻei kua o nā ana, e kamaʻilio i ka nń ku maʻi. E like me ka mea antiarrhythmic Agena ua ana pili lidocaine. Ua Ua lawelawe intravenously ma 1 mg no kilogram o ka hoʻomanawanui kaumaha. IeAUPIIe, IAa IO, keia mahele lāʻau mai i 100 mg, a ua lawelawe i loko o kekahi mau minuke. Ināʻaʻohe kanawai no 15 minuke ua hoʻohana hou i ka makaukau ma ka ia laʻau heluna. Inā ventricular tachycardia ua pu ma ka manaʻo koikoi kulu, hoomahuahua ia ma ka hoʻohana 'ana i pressor amines. Kēia, e hoʻihoʻi aku sinus pāpana. Intoxication cardiac glycosides ventricular tachycardia ia me ka potasiuma koloriside a me ka lidocaine a me ka lāʻau "obzidan" ua hoʻohana 'ia.

Ka mau nō lā hoʻi o ka hana maikaʻiʻole ma hope o ke ola naʻau kōmi

I ka wā o ka pāpana hoihoi hou oaeuiinoe prognosis a me ka hoʻomanawanui'ōnaehana manao e huki mai. He ua hoonohoia ma ka lāʻau Inc a mea hoʻonoho cardioverter-defibrillator a catheter ablation. Aia i kekahi hui lapaau koho. Ka mea, i ana hoʻohana 'ia ma laila mea he nui mall abnormality o ka naau. Catheter ablation, no kekahi laʻana, ke hoomahuahua i ka hoʻokōʻana o antiarrhythmic Inc, paha e emi i ka hookuuia ana, o ka mea e kanu pū cardioverter-defibrillator.